Machine Algorithm IDs Unruptured Cerebral Aneurysms That Get Missed
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Sept. 25, 2023 -- Unruptured cerebral aneurysms (UCAs) of sizes that warrant attention and possibly treatment that are missed in routine care can be identified by a machine learning algorithm, according to a study published online Sept. 13 in Stroke: Vascular and Interventional Neurology.
Hyun-Woo Kim, M.D., from UTHealth McGovern Medical School in Houston, and colleagues assessed the performance of a machine learning algorithm to identify UCAs among patients who underwent computed tomography angiography for evaluation of possible stroke. The images were analyzed using a convolutional deep neural network (Viz ANEURYSM) trained to identify UCAs ≥4 mm.
The researchers found that 4.2 percent of the 1,191 computed tomography angiograms performed during the study period were flagged by the machine learning algorithm as possibly demonstrating a UCA; 31 of these 50 cases were confirmed as true positive (positive predictive value, 62 percent). A total of 36 true aneurysms were identified, with four cases of multiple aneurysms. The internal carotid artery was the most common location (42 percent). Of the 36 cases, 10 and 24 were not noted in the clinical radiology report or clinical notes (median size, 4.4 mm) and were not referred for follow-up (median size, 4.4 mm), respectively. Fifteen of the 24 aneurysms not referred for follow-up had been noted in the radiology report. Overall, five of the 15 cases detected but not referred had a diameter greater than 7 mm.
"These findings suggest that a machine learning-based approach that can assist with screening for UCAs, and alerting the clinical care teams may improve the care of patients with UCAs," the authors write.
Several authors disclosed ties to medical device and technology companies, including Viz.ai., which funded the study.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.